A preliminary cost-effectiveness analysis of hepatitis E vaccination among pregnant women in epidemic regions

Human Vaccines & Immunotherapeutics
Yueyuan ZhaoBei Wang

Abstract

Objective To estimate the cost-effectiveness of hepatitis E vaccination among pregnant women in epidemic regions. Methods A decision tree model was constructed to evaluate the cost-effectiveness of 3 hepatitis E virus vaccination strategies from societal perspectives. The model parameters were estimated on the basis of published studies and experts' experience. Sensitivity analysis was used to evaluate the uncertainties of the model. Results Vaccination was more economically effective on the basis of the incremental cost-effectiveness ratio (ICER< 3 times China's per capital gross domestic product/quality-adjusted life years); moreover, screening and vaccination had higher QALYs and lower costs compared with universal vaccination. No parameters significantly impacted ICER in one-way sensitivity analysis, and probabilistic sensitivity analysis also showed screening and vaccination to be the dominant strategy. Conclusion Screening and vaccination is the most economical strategy for pregnant women in epidemic regions; however, further studies are necessary to confirm the efficacy and safety of the hepatitis E vaccines.

References

Apr 22, 1995·Lancet·M S KhurooS Jameel
Feb 3, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J J BergeM Weinberg
Feb 13, 2001·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·S P JaiswalD S Chitnis
Feb 24, 2001·The American Journal of Gastroenterology·H OgawaI Sasaki
Aug 18, 2001·Intervirology·A Safary
Oct 13, 2001·Trends in Molecular Medicine·S U Emerson, R H Purcell
Mar 7, 2003·Indian Journal of Pediatrics·Sarman SinghS K Panda
Jun 27, 2003·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Vincent KaramHenri Bismuth
Jan 14, 2004·The Journal of Obstetrics and Gynaecology Research·Arif Serhan CevriogluFatih Aksoy
Nov 1, 2005·Transactions of the Royal Society of Tropical Medicine and Hygiene·Sonia K StoszekG Thomas Strickland
Jun 2, 2006·Obstetrics and Gynecology·Scott RobertsGeorge D Wendel
Mar 3, 2007·The New England Journal of Medicine·Mrigendra Prasad ShresthaBruce L Innis
Jul 4, 2007·Annals of Internal Medicine·Sharda PatraShiv Kumar Sarin
Jul 22, 2009·Virology Journal·Andrew A AdjeiTheophilus K Adiku
Nov 17, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Richard H BeigiBruce Y Lee
Sep 14, 2010·Lancet
Oct 7, 2010·Vaccine·Bruce Y LeeKenneth J Smith
Apr 5, 2011·Virus Research·Rakesh Aggarwal
May 31, 2011·Virus Research·Saleem Kamili
Jun 10, 2011·American Journal of Obstetrics and Gynecology·Evan R MyersGeeta K Swamy
Dec 14, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ting WuNing-Shao Xia
May 3, 2012·Lancet·Nassim KamarHarry R Dalton
Jan 9, 2013·Human Vaccines & Immunotherapeutics·Sara BoccaliniPaolo Bonanni
Jun 6, 2013·Emerging Infectious Diseases·Jamal A AhmedNina Marano
Sep 24, 2013·Vaccine·Samuel K PeasahMarc-Alain Widdowson
Sep 24, 2013·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·Fen HuangShenrong Jing
Oct 11, 2013·Journal of the Royal Army Medical Corps·Dennis A Freshwater
Dec 19, 2013·Hepatitis Monthly·Zakieh Rostamzadeh KhamenehHamid-Reza Khalkhali
Jan 15, 2014·Cytokine·Ashok KumarShashi Sharma
Jan 18, 2014·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·María Teresa Pérez-GraciaMaría Luisa Mateos-Lindemann
Mar 13, 2014·Human Vaccines & Immunotherapeutics·Karen M ClementsDerek A Misurski
Mar 14, 2014·The Journal of General Virology·Purabi Deka BosePremashis Kar
May 24, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Emily S GurleyStephen P Luby
Sep 4, 2014·Annals of Medical and Health Sciences Research·Nr ShindeYv Bansod
Feb 26, 2015·Human Vaccines & Immunotherapeutics·Shao-Wei LiNing-Shao Xia
Mar 4, 2015·Open Forum Infectious Diseases·Kenrad E NelsonAlain B Labrique

❮ Previous
Next ❯

Citations

Mar 17, 2018·BioMed Research International·Juliana Gil MelgaçoMarcelo Alves Pinto
Oct 14, 2020·Nature Reviews. Gastroenterology & Hepatology·Norah A TerraultGonzague Jourdain
Mar 22, 2020·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Michael J AnkcornFrank G Sandmann
Feb 1, 2022·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·Patrick Behrendt, Heiner Wedemeyer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.